Loading BMY charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading BMY comparable companies…
| BMYBristol Myers Squibb Co.(opens in a new tab) | $128.25B | $50.03B | +4.2% | 69.2% | — | 2.56× | 13.9× |
|---|---|---|---|---|---|---|---|
| PFEPfizer Inc.(opens in a new tab) | $173.82B | $63.70B | −0.2% | 73.2% | — | 2.73× | 40.1× |
| MRKMerck & Co., Inc.(opens in a new tab) | $369.36B | $66.57B | +4.6% | 73.0% | — | 5.55× | 118.7× |
| ABBVAbbVie Inc.(opens in a new tab) | $522.12B | $64.39B | +10.4% | 71.5% | 26.2% | 8.11× | 83.3× |
| GILDGilead Sciences, Inc.(opens in a new tab) | $213.86B | $30.99B | +6.5% | 79.9% | −7.6% | 6.90× | — |
| Medianpeers, excl. BMY | $291.61B | $64.04B | +5.6% | 73.1% | 9.3% | 6.22× | 83.3× |